08.00 08.20 08.30 REGISTRATION & COFFEE Welcome Speech Opening Speech: “Cancer Drug Pricing” David H. Howard, Department of Health Policy and Management, Emory University 08.50 Pharma-Biotech BD&L Featuring: Catherine Pickering, Head of Oncology Licensing, EMD Serono, Inc. Ioannis Sapountzis, Global Head of Oncology Business Development & Licensing, Boehringer Ingelheim John DeYoung, Vice President, Oncology BD, Pfizer Peter Sandor, VP, Global Marketing, TA Head Oncology, Amgen Tanja Weber, Head BD for Sanofi Oncology, Sanofi 09.50 Immunotherapeutics: ADCs and Combination Therapies Chaired by: James Mulé, Associate Center Director for Translational Research, Michael McGillicuddy Endowed Chair of Melanoma Research and Treatment, and Director of Cell-based Therapies, Moffitt Cancer Center Featuring: Elma Hawkins, President and CEO, Lion Biotechnologies Mike Attar, Executive Director, Business Development, Celgene Richard Gregory, EVP & Chief Scientific Officer, ImmunoGen, Inc. Sharon Benzeno, Senior Director, New Product Development, Adaptive Biotechnologies 10.35 10.50 11.15 COFFEE BREAK Keynote Speech: “Pitfalls and promise of genetically modified T cells” Professor Laurence Cooper, MD Anderson Cancer Center T-Cell Therapeutics Chaired by: Boris Peaker, Managing Director, Cowen and Company Featuring: André Choulika, Chairman and CEO, Cellectis Arie Belldegrun*, Chairman, President and CEO, Kite Pharma David Donabedian, Vice President & Head, Ventures and Early Stage Collaborations, AbbVie, Inc. Gregory Frost, SVP, Head of Health Sector, Intrexon Corporation Kevin Slawin, CMO & CTO, Bellicum Pharmaceuticals, Inc. Stephen Rubino, Global Head, BD and New Products Marketing, Cell & Gene Therapy Unit, Novartis Pharmaceuticals Corporation *to be confirmed 12.15 Academic Medical Center Collaborations Chaired by: Howard J. Fingert, Senior Medical Director, Internal and External Innovation for Oncology TA, Takeda Pharmaceuticals Featuring: Benjamin Thorner*, VP, Head of North American Innovation Hubs, Merck Research Laboratories Ferran Prat, VP, Strategic Industry Ventures, MD Anderson Cancer Center Issi Rozen, Senior Director, Strategic Alliances, Broad Institute of MIT and Harvard Kuldeep Neote, Senior Director, New Ventures/Scout, J&J Innovation Center-Boston O. Prem Das, Chief Business Development Officer, Dana-Farber Cancer Institute *to be confirmed 13.00 14.00 16.00 NETWORKING LUNCH Presentation Track A Interview 16.30 Investment Roundtable Chaired by: Biren Amin, Managing Director and Senior Equity Research Analyst, Jefferies Featuring: Joseph Sum, Analyst, Director of Research, EcoR1 Capital, LLC Margarita Chavez, Director, Venture Investments, AbbVie Peter Thompson, Private Equity Partner, OrbiMed Advisors LLC Thilo Schroeder, Partner, Nextech Invest Ltd. 17.30 NETWORKING RECEPTION Supported by: Presentation Track B